On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2012: Volume 17/ Issue 17 Article 1
Back to Table of Contents
Download (pdf)

Eurosurveillance, Volume 17, Issue 17, 26 April 2012
Vaccine registers – experiences from Europe and elsewhere
  1. Health Protection Agency (HPA) – Colindale, London, United Kingdom

Citation style for this article: Pebody R. Vaccine registers – experiences from Europe and elsewhere. Euro Surveill. 2012;17(17):pii=20159. Available online:
Date of submission: 23 April 2012

In this special issue, published in two parts, Eurosurveillance has presented a series of articles from countries in Europe, Australia and Canada, describing their various experiences with the introduction of vaccine registers [2-11]. Vaccine registers are population-based systems that contain core individual-level information on the population, together with information on immunisation status – usually for the childhood vaccination programmes. These systems are linked to a variety of programme management, surveillance and research tasks [1].

The lessons outlined in this special issue of Eurosurveillance illustrate the many potential opportunities of such systems and some of the challenges and the alternatives that may be available (Table).

Table. Characteristics of immunisation registers in six European countries, Australia and Canada

There are a series of core attributes for any successful national vaccine register. Firstly, accurate and up-to-date ascertainment of individual-level demographic data of the population of interest is needed, as these constitute the denominator for calculation of coverage data. A small number of countries illustrate how this has been achieved through access to their national administrative population or universal healthcare registers based on personal identifiers/health numbers (2-4,7). Some of the systems presented are able to electronically transfer this population data in real-time and can automatically take into account new births, families moving address, children dying etc. Such innovations can help to minimise some of the traditional denominator problems of ghosting and unregistered populations. Secondly, information on vaccine status (numerator data) on this population needs to be both accurate and complete. Examples are provided of vaccine programmes using barcodes on vaccine vials, which can be used to record information on vaccine dose, batch number and name, thus reducing data entry time and errors [6,11]. Thirdly, register systems need to be flexible as national vaccine programmes are continuously evolving, with the introduction of new vaccines and changes in current childhood immunisation programmes. The registers are able to adapt to such changes. Finally, as personal identifiable data are required, which is highly sensitive, the importance of developing robust data security and confidentiality mechanisms to protect these systems are highlighted by L Trogstad et al. [2].

The articles illustrate how vaccine registers can be used both as a management tool and for surveillance purposes. As a management tool, countries show how they have used registers to deliver their immunisation programmes. Examples are provided how they can be used to purchase vaccines and monitor supply [3,8]; how they can function as patient call-recall systems – producing invitation and reminder letters [3,5-8]; how they can provide certificates of vaccination for patients [2] and also how they can be linked to incentive schemes for health practitioners [7].

Vaccine registers can also be used as important surveillance tools to monitor national immunisation programmes. Data from such systems can be used to monitor vaccine uptake from national through to local level. This can identify unvaccinated sub-populations (whether by age, geography or particular risk group) and to ensure vaccine uptake is optimal in these pockets. The availability of unique personal identifiers provides the opportunity to link vaccine registers to disease registers and thus identify specific health outcomes. This provides the ability to evaluate the vaccine effectiveness and to investigate vaccine safety signals of existing and new vaccine programmes. Finally, there are examples of these systems being used to answer specific research questions, seeking informed consent from individuals on the national register to take part in vaccine trials or questionnaire surveys [3].

The challenges of developing such national systems are outlined. Firstly, the development of such systems is a significant undertaking, not least from the IT perspective, requiring substantial investment and careful planning. Secondly a number of countries have decentralised health structures, which create difficulties in establishing such a national register. Some countries have overcome this problem, at least to a certain extent, by regions/provinces creating register networks. Such networks require common national standards and issues can remain around ensuring an accurate denominator. Thirdly, some countries have strict information governance regulations which do not allow personal identifiable data to be kept at national level [9]. Finally, the role of the private sector in vaccine delivery in some settings (as opposed to the central purchase of vaccine by the public sector) can provide a challenge to properly estimating the numerator. 

The special issue highlights some of the future directions of travel. Countries which already have national vaccine registers are now extending these to whole life and teenage and adult vaccine programmes. The potential for synergy (and efficiencies) with other public health programmes such as maternal screening/neonatal screening is being explored. There is an increasing automation of operational processes from patient reminders through to scanning barcoded vaccine products. These need to be more standardised and at least for the latter, buy-in from the vaccine manufacturers is required. The full surveillance and research potential of such systems (under appropriate governance) is only just being realised, particularly through linkage to other electronic health records and through direct contact with patients. For some countries, there are important operational, financial and governance challenges to their establishment, for example decentralised health systems or concerns about data confidentiality. Alternative solutions need to be found, and some countries have tried to collect vaccine uptake data in other ways – such as by the use of telephone surveys [9]. Despite these challenges, national vaccine registers can play a key role in the delivery of national immunisation programmes in many countries and make important contributions to achieving national and international control and elimination targets.


  1. Johansen K, Lopalco PL, Giesecke J. Immunisation registers – important for vaccinated individuals, vaccinators and public health. Euro Surveill. 2012;17(16):pii=20151. Available from:  
  2. Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register – SYSVAK. Euro Surveill. 2012;17(16):pii=20147. Available from:   
  3. van Lier A, Oomen P, de Hoogh P, Drijfhout I, Elsinghorst B, Kemmeren J, et al. Præventis, the immunisation register of the Netherlands: a tool to evaluate the National Immunisation Programme. Euro Surveill. 2012;17(17):pii=20153. Available from:
  4. Grove Krause T, Jakobsen S, Haarh M, Mølbak K. The Danish vaccination register . Euro Surveill. 2012;17(17):pii=20155. Available from:  
  5. Amirthalingam G, White J, Ramsay M. Measuring childhood vaccine coverage in England: the role of Child Health Information Systems . Euro Surveill. 2012;17(16):pii=20149. Available from:  
  6. Bernal-González PJ, Navarro-Alonso JA, Pérez-Martín JJ. Computerised vaccination register for the Murcia region, Spain, 1991 to 2011. Euro Surveill. 2012;17(16):pii=20150. Available from:
  7. Chin LK, Crawford NW, Rowles G, Buttery JP. Australian immunisation registers: established foundations and opportunities for improvement. Euro Surveill. 2012;17(16):pii=20148. Available from:  
  8. Alfonsi V, D'Ancona F, Rota MC, Giambi C, Ranghiasci A, Iannazzo S, et al. Immunisation registers in Italy: a patchwork of computerisation . Euro Surveill. 2012;17(17):pii=20156. Available from:
  9. Siedler A, Rieck T, Reuss A, Walter D, Poggensee G, Poethko-Müller C, et al. Estimating vaccination coverage in the absence of immunisation registers – the German experience. Euro Surveill. 2012;17(17):pii=20152. Available from:
  10. Aguilar I, Reyes M, Martínez-Baz I, Guevara M, Albéniz E, Belza MJ, et al. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain . Euro Surveill. 2012;17(17):pii=20154. Available from:
  11. Laroche JA, Diniz AJ. Immunisation registers in Canada: progress made, current situation, and challenges for the future. Euro Surveill. 2012;17(17):pii=20158. Available from:

Back to Table of Contents
Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.